Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aon plc

Founders Pat Ryan W. Clement Stone

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$45M
Portfolio companies 12
Rounds per year 0.29
Lead investments 3
Exits 1
Key employees 22

Areas of investment

  • Medical
  • Health Care
  • Biotechnology
  • Software
  • Consumer Electronics
Summary

Aon plc appeared to be the Corporate Investor, which was created in 1919. The company was established in Europe in United Kingdom. The main office of represented Corporate Investor is situated in the London.

The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Psilos Group, Kohlberg Kravis Roberts, KECALP.

Besides them, we counted 22 critical employees of this fund in our database.

Among the most popular fund investment industries, there are Hospital, Medical. Among the most popular portfolio startups of the fund, we may highlight Definity Health. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

The top activity for fund was in 2000. The higher amount of exits for fund were in 2004. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acartha Group Missouri, St Louis, United States
Chicago Venture Summit Chicago, Illinois, United States
China Startup China, Guangdong, Shenzhen
Commonwealth Research Commercialization Fund -
First Rate Arlington, Texas, United States
Leumi Partners Israel, Tel Aviv, Tel Aviv District
Madison Wells Media California, Los Angeles, United States
Main Street Capital Houston, Texas, United States
Medinnova England, Leicester, United Kingdom
MK Energy and Infrastructure Connecticut, Stamford, United States
Moai Capital Venture Italy, Lombardy, Milan
TACK Ventures Brooklyn, New York, United States
The Batchery Angels -
TSK Asturias, Gijón, Spain
View Worldwide Technology China, Guangdong, Zhuhai
WDI GROUP Japan, Tokyo
Weifang Hongtu Ziben China, Japan, Kagoshima Prefecture
Winning Health Technology Group China, Shanghai
Zorea Ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rznomics

Biopharma
Biotechnology
$32M08 Jun 2022 South Korea, Gangwon-do, South Korea

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aon plc?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 12
Average round size 45M
Rounds per year 0.29
Peak activity year 2022
Lead investments 3
Exits 1
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rznomics

Biopharma
Biotechnology
$32M08 Jun 2022 South Korea, Gangwon-do, South Korea
Crunchbase icon

Content report

The following text will be sent to our editors: